Remdesivir Market Report 2026

Remdesivir Market Overview

• Remdesivir market size has reached to $8.52 billion in 2025 • Expected to grow to $17.96 billion in 2030 at a compound annual growth rate (CAGR) of 12.6% • Growth Driver: Role Of Government Expenditure In Driving Remdesivir Market Growth • North America was the largest region in 2025 and Middle East is the fastest growing region.

What Is Covered Under Remdesivir Market?

Remdesivir refers to a class of drugs called antivirals that are used to treat hospitalized adults and children 28 days of age and older who weigh at least 6.6 pounds for COVID-19 disease 2019 (COVID-19 infection) caused by the SARS-CoV-2 virus (3 kg), who have a significant risk of developing severe COVID-19, which could result in hospitalization and death. The main routes of administration in remdesivir are oral and intravenous. Intravenous generally relates to a method of administering a drug or other substance into a vein using a syringe or tube. The different dosage forms include tablets, frozen solutions, and lyophilized solutions and are distributed through various channels such as hospitals, clinics, drug stores/pharmacies, online, and others.

What Is The Remdesivir Market Growth Forecast?

The remdesivir market size is expected to see rapid growth in the next few years. It will grow to $17.96 billion in 2030 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to development of novel remdesivir formulations, increasing adoption of oral and ready-to-use injectable solutions, expansion of telemedicine-supported antiviral administration, rising government initiatives for covid-19 management, growth in online pharmacy and home delivery services. Major trends in the forecast period include rising demand for intravenous antiviral therapies, increased adoption of oral antiviral formulations, growth in hospitalization and critical care treatments for covid-19, expansion of online and retail pharmacy distribution channels, development of ready-to-use injectable and lyophilized powder solutions.

Global Remdesivir Market Segmentation

1) By Route Of Administration: Oral, Intravenous 2) By Dosage Form: Tablets, Frozen Solution, Lyophilized Solution 3) By Distribution Channel: Hospitals, Clinics, Drug Stores/Pharmacies, Online, Other Distribution Channels Subsegments: 1) By Oral: Tablet Formulation, Liquid Formulation 2) By Intravenous: Ready-To-Use Injectable, Lyophilized Powder For Injection

What Are The Drivers Of The Remdesivir Market?

The increasing government expenditure is expected to propel the growth of the remdesivir market going forward. Government expenditure, also known as government spending, refers to the total amount of money that a government or public sector entity allocates and disburses to finance its operations, programs, services, and projects. Government expenditure is instrumental in the growth and accessibility of Remdesivir, especially during public health crises. By providing funding, regulatory support, purchasing power, and research investments, governments can contribute to the availability and affordability of this critical antiviral medication. For instance, in April 2025, according to the American Medical Association, a US-based Professional organizations, in 2023, U.S. health spending climbed 7.5% to $4.9 trillion, or $14,570 per capita, outpacing the 4.6% increase seen in 2022. Therefore, the increasing government spending is driving the growth of the remdesivir industry. The increasing demand for clinical trials and research is expected to propel the growth of the remdesivir market going forward. Clinical trials and research refer to the systematic and carefully designed investigations conducted in the field of medicine and healthcare to evaluate the safety and efficacy of various medical interventions, treatments, drugs, medical devices, diagnostic procedures, or healthcare strategies. Clinical trials are conducted to evaluate the efficacy and safety of Remdesivir in treating viral infections, including diseases like COVID-19. These trials provide scientific evidence of the drug's effectiveness in reducing the severity and duration of symptoms and its safety profile. For instance, in May 2023, according to Xtalks, a Canada-based digital health company, 452,604 clinical studies were registered in 2023 and 64,838 of the total number of registered studies are actively seeking participants. Therefore, the increasing demand for clinical trials and research is driving the growth of the remdesivir industry. The rising healthcare expenditure is expected to propel the growth of the Remdesivir market going forward. Healthcare expenditure refers to the total financial resources spent by individuals, organizations, or governments on preventing, treating, and managing health conditions. Healthcare expenditure is increasing due to advancements in medical technology, as new diagnostic tools, treatments, and innovative therapies often come at higher costs, leading to greater overall spending in healthcare. Higher healthcare expenditure supports the use of remdesivir by enabling governments and hospitals to procure sufficient supplies, improve distribution infrastructure, and ensure timely treatment for COVID-19 patients, ultimately enhancing patient access and treatment outcomes. For instance, in December 2024, according to the Centers for Medicare & Medicaid Services, a US-based agency responsible for administering the Medicare and Medicaid programs, in 2023, U.S. health care expenditures increased by 7.5%, climbing to $4.9 trillion, or roughly $14,570 for each individual. Therefore, the rising healthcare expenditure is driving the growth of the Remdesivir industry.

Key Players In The Global Remdesivir Market

Major companies operating in the remdesivir market are Gilead Sciences Inc., BrightGene Bio-Medical Technology Co Ltd, Hainan Haiyao Co. Ltd., Sichuan Kelun Pharmaceutical Co. Ltd., Hunan Warrant Pharmaceutical, Cipla Limited, Dr Reddy’s Laboratories Ltd., Shenzhen BORUI Pharmaceutical Technology Co. Ltd., Hetero Labs Limited, Mylan N.V., Zydus Cadila Health Care Limited, Syngene International Limited, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Teva Pharmaceutical Industries, Ferozsons Laboratories Limited, Jubilant Life Sciences, Laurus Labs, Macleods Pharmaceuticals, Natco Pharma, Sandoz Group AG, Strides Pharma Science Limited, Torrent Pharmaceuticals, Beximco Pharmaceuticals Ltd., Fresenius Kabi, Gland Pharma Limited, Hikma Pharmaceuticals, Lark Laboratories

Regional Insights

North America was the largest region in the remdesivir market in 2025. Middle East is expected to be the fastest growing region in the remdesivir market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Remdesivir Market?

The remdesivir market consists of sales of nucleotide analogue and Veklury. Values in this market are """"factory gate values,"""" that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Remdesivir Market Report 2026?

The remdesivir market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the remdesivir industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.